On August 16, 2023, ImpediMed Limited announced the Company?s board recommended the shareholders to vote against the shareholder proposals for the removal of Donald Williams, Amit Patel, David Anderson and Daniel Sharp and the appointment of McGregor Grant, Christine Emmanuel-Donnelly, Andrew Grant and Janelle Delaney as the director of the Company at the General Meeting of shareholders of the Company scheduled to be held on September 28, 2023.